Cargando…

Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals

BACKGROUND: Cardiovascular and renal diseases (CVRD) are major causes of mortality in individuals with type 2 diabetes (T2D). Studies of lifetime risk have neither considered all CVRD together nor the relative contribution of major risk factors to combined disease burden. METHODS: In a population-ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ruiqi, Mamza, Jil Billy, Morris, Tamsin, Godfrey, George, Asselbergs, Folkert W., Denaxas, Spiros, Hemingway, Harry, Banerjee, Amitava
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822817/ https://www.ncbi.nlm.nih.gov/pubmed/35130878 http://dx.doi.org/10.1186/s12916-022-02234-2

Ejemplares similares

Correction to: Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals
por: Zhang, Ruiqi, et al.
Publicado: (2022)

Identifying subtypes of chronic kidney disease with machine learning: development, internal validation and prognostic validation using linked electronic health records in 350,067 individuals
por: Dashtban, Ashkan, et al.
Publicado: (2023)

Lower risk of hospitalization for heart failure, kidney disease and death with sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: A retrospective cohort study in UK primary care
por: Idris, Iskandar, et al.
Publicado: (2021)

A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney disease
por: Dashtban, Ashkan, et al.
Publicado: (2022)

Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study
por: Pasea, Laura, et al.
Publicado: (2023)

Significant reduction in chronic kidney disease progression with sodium‐glucose cotransporter‐2 inhibitors compared to dipeptidyl peptidase‐4 inhibitors in adults with type 2 diabetes in a UK clinical setting: An observational outcomes study based on international guidelines for kidney disease
por: Idris, Iskandar, et al.
Publicado: (2022)

Risk factors for incident heart failure in age‐ and sex‐specific strata: a population‐based cohort using linked electronic health records
por: Uijl, Alicia, et al.
Publicado: (2019)

Models for mortality require tailoring in the context of the COVID-19 pandemic – Authors' reply
por: Banerjee, Amitava, et al.
Publicado: (2020)

Transforming and evaluating electronic health record disease phenotyping algorithms using the OMOP common data model: a case study in heart failure
por: Papez, Vaclav, et al.
Publicado: (2021)

A population‐based study of 92 clinically recognized risk factors for heart failure: co‐occurrence, prognosis and preventive potential
por: Banerjee, Amitava, et al.
Publicado: (2022)

The tip of the iceberg: challenges of accessing hospital electronic health record data for biological data mining
por: Denaxas, Spiros C., et al.
Publicado: (2016)

Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
por: Allan, Victoria, et al.
Publicado: (2017)

Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1 937 360 people in England: lifetime risks and implications for risk prediction
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2015)

Big data from electronic health records for early and late translational cardiovascular research: challenges and potential
por: Hemingway, Harry, et al.
Publicado: (2018)

Neutrophil Counts and Initial Presentation of 12 Cardiovascular Diseases: A CALIBER Cohort Study
por: Shah, Anoop Dinesh, et al.
Publicado: (2017)

Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: a CALIBER cohort study
por: Shah, Anoop Dinesh, et al.
Publicado: (2016)

Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
por: Birkeland, Kåre I., et al.
Publicado: (2020)

Subtypes of atrial fibrillation with concomitant valvular heart disease derived from electronic health records: phenotypes, population prevalence, trends and prognosis
por: Banerjee, Amitava, et al.
Publicado: (2019)

Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors
por: Pasea, Laura, et al.
Publicado: (2017)

Low-density lipoprotein cholesterol and atrial fibrillation; A Mendelian randomization study using UK-Biobank data
por: Katsoulis, Michail, et al.
Publicado: (2017)

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
por: Rapsomaniki, Eleni, et al.
Publicado: (2014)

Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study
por: Anyanwagu, Uchenna, et al.
Publicado: (2017)

Estimating the Effect of Reduced Attendance at Emergency Departments for Suspected Cardiac Conditions on Cardiac Mortality During the COVID-19 Pandemic
por: Katsoulis, Michail, et al.
Publicado: (2020)

Machine learning for subtype definition and risk prediction in heart failure, acute coronary syndromes and atrial fibrillation: systematic review of validity and clinical utility
por: Banerjee, Amitava, et al.
Publicado: (2021)

Temporal trends in heart failure medication prescription in a population-based cohort study
por: Uijl, Alicia, et al.
Publicado: (2021)

Weight Change and the Onset of Cardiovascular Diseases: Emulating Trials Using Electronic Health Records
por: Katsoulis, Michail, et al.
Publicado: (2021)

POS-894 PREDICTING PANDEMIC-RELATED EXCESS-DEATH USING PRE-PANDEMIC RISK OF MORTALITY IN INDIVIDUALS WITH CHRONIC KIDNEY DISEASE
por: Dashtban, M., et al.
Publicado: (2022)

How Does Cardiovascular Disease First Present in Women and Men?: Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People
por: George, Julie, et al.
Publicado: (2015)

Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients
por: George, Julie, et al.
Publicado: (2017)

Time spent at blood pressure target and the risk of death and cardiovascular diseases
por: Chung, Sheng-Chia, et al.
Publicado: (2018)

Socioeconomic Deprivation and the Incidence of 12 Cardiovascular Diseases in 1.9 Million Women and Men: Implications for Risk Prediction and Prevention
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2014)

Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
por: Birkeland, Kåre I., et al.
Publicado: (2020)

Association between clinical presentations before myocardial infarction and coronary mortality: a prospective population-based study using linked electronic records
por: Herrett, Emily, et al.
Publicado: (2014)

Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population‐based linked electronic health record cohort study in 2.1 million people
por: Koudstaal, Stefan, et al.
Publicado: (2016)

Critical appraisal of artificial intelligence-based prediction models for cardiovascular disease( )
por: van Smeden, Maarten, et al.
Publicado: (2022)

Clinical academic research in the time of Corona: A simulation study in England and a call for action
por: Banerjee, Amitava, et al.
Publicado: (2020)

Séminaire Bourbaki : exposés 382–399
por: Collective
Publicado: (1972)

Polygenic risk scores for coronary artery disease and subsequent event risk amongst established cases
por: Howe, Laurence J, et al.
Publicado: (2020)

Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records
por: Pikoula, Maria, et al.
Publicado: (2019)

Natural language processing for disease phenotyping in UK primary care records for research: a pilot study in myocardial infarction and death
por: Shah, Anoop D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_84veile4uibjkj84f4h67lal5r